Changeflow GovPing Pharma & Drug Safety Patent Application: Production Method for Produ...
Routine Notice Added Draft

Patent Application: Production Method for Product to Prevent Membrane Clogging

Favicon for changeflow.com ChangeBridge: Patent Apps - Peptides (C07K)
Published November 28th, 2025
Detected March 26th, 2026
Email

Summary

The USPTO has published a patent application from FUJIFILM Corporation detailing a production method for a product that aims to prevent membrane clogging during cell culture. The method involves specific mathematical expressions related to poloxamer concentration, product concentration, and hydrophobicity index to optimize the cell culture process.

What changed

This document is a published patent application (US20260085110A1) from FUJIFILM Corporation, filed on November 28, 2025. It describes a novel production method for a product intended to prevent membrane clogging and maintain productivity during cell culture. The core of the invention lies in satisfying specific mathematical conditions related to the concentration of poloxamer (P), product (C), hydrophobicity index (S), and valine residue ratio (V) in the culture solution, as defined by Expression 1 and Expression 5.

As this is a patent application, it does not impose immediate regulatory obligations or penalties on entities. However, companies involved in cell culture-based production, particularly in the pharmaceutical and biotechnology sectors, may find this method relevant for optimizing their manufacturing processes. Compliance officers should note this as a potential technological advancement in the field, which could influence future industry standards or practices. No specific compliance deadline or action is required based on this publication alone.

Source document (simplified)

← USPTO Patent Applications

PRODUCTION METHOD FOR PRODUCT

Application US20260085110A1 Kind: A1 Mar 26, 2026

Assignee

FUJIFILM Corporation

Inventors

Shinichi NAKAI, Atsushi INADA, Katsuhiro SHIMONO, Shino OHIRA, Noriyuki OHASHI, Yuanzhong LI, Ichihiko HASHIMOTO

Abstract

An object of the present invention is to provide a method that makes it possible to prevent clogging of a membrane during culture and prevent a decrease in productivity in a production method for a product by cell culture. According to the present invention, there is provided a production method for a product, including: culturing cells in a culture solution, in which, in a case where a poloxamer concentration in the culture solution is denoted by P (g/L), a product concentration in the culture solution is denoted by C (g/L), a hydrophobicity index SAP value of the product is denoted by S, and a ratio of a valine residue of an L chain variable region of the product is denoted by V (%), at least one of 1.5P+3C+0.93S≤378 (Expression 1) or P+3.5C+1.9V≤29 (Expression 5) is satisfied.

CPC Classifications

C07K 16/00 C07K 2317/14

Filing Date

2025-11-28

Application No.

19403604

View original document →

Named provisions

Abstract Assignee Inventors

Classification

Agency
USPTO
Published
November 28th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260085110A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Cell Culture Production
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Biotechnology Manufacturing Processes

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Peptides (C07K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.